122 related articles for article (PubMed ID: 9028162)
1. [False positive FDP test associated with malignant lymphoma].
Kitazume K; Usuki K; Endo M; Osawa M; Iki S; Urabe A
Rinsho Ketsueki; 1997 Jan; 38(1):52-7. PubMed ID: 9028162
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
Wilson JE; Thornton RD
Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
Chen JP; Williams TK; Legendre AM
Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of latex agglutination tests for fibrin-fibrinogen degradation products in the forensic identification of menstrual blood.
Akutsu T; Watanabe K; Motani H; Iwase H; Sakurada K
Leg Med (Tokyo); 2012 Jan; 14(1):51-4. PubMed ID: 22189168
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid factor interference with the latex agglutination test for fibrin degradation products.
Rutstein JE; Holahan JR; Lyons RM; Pope RM
J Lab Clin Med; 1978 Oct; 92(4):529-35. PubMed ID: 712192
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
Kaizu K; Ito Y; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
[TBL] [Abstract][Full Text] [Related]
9. [Studies on the fragments of FDP in 3 non-DIC patients with increased FDP levels in the sera].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Shinoda T; Nakahata T; Saitoh H
Rinsho Byori; 1993 Feb; 41(2):220-6. PubMed ID: 8361025
[TBL] [Abstract][Full Text] [Related]
10. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
[TBL] [Abstract][Full Text] [Related]
11. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
12. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
Kaizu K; Ito Y; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
Marder VJ; Cruz GO; Schumer BR
Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
15. [Urinary cross-linked FDP in various renal diseases].
Inuma H
Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
[TBL] [Abstract][Full Text] [Related]
16. [Persistent discrepancy between FDP and D-dimer in a patient with acute leukemia].
Sato N; Takahashi H; Nikuni K; Seki Y; Wada K; Tatewaki W; Shibata A
Rinsho Ketsueki; 1995 Mar; 36(3):212-7. PubMed ID: 7783324
[TBL] [Abstract][Full Text] [Related]
17. Unreliability of current serum fibrin degradation product (FDP) assays.
Gaffney PJ; Perry MJ
Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
[TBL] [Abstract][Full Text] [Related]
18. False-positive reaction for fibrin degradation products due to a monoclonal (IgM lambda) cryoglobulin with warm-reactive antibody activity for rabbit IgG.
Hammouda W; Moroz LA
Am J Med; 1987 Jun; 82(6):1263-8. PubMed ID: 2440301
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical implications of heparin-associated false positive tests for serum fibrin(ogen) degradation products.
Connaghan DG; Francis CW; Ryan DH; Marder VJ
Am J Clin Pathol; 1986 Sep; 86(3):304-10. PubMed ID: 3751995
[TBL] [Abstract][Full Text] [Related]
20. Vital reactions in rat skin wounds by quantitation of fibrin.
Fujitani N; Matoba R; Inoue H; Takabe F
Nihon Hoigaku Zasshi; 1991 Dec; 45(5-6):375-8. PubMed ID: 1811102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
